Palisade bio announces topline results from u.s. phase 2 profile study evaluating lb1148 for post-surgical abdominal adhesions

– study did not achieve primary efficacy endpoint of reducing adhesions in lb1148 treated patients compared to placebo treated patients post bowel resection surgery

PALI Ratings Summary

PALI Quant Ranking